Latest Advances

  • Condition: Schizophrenia
  • Journal: Psychopharmacology bulletin
  • Treatment Used: Lumateperone
  • Number of Patients: 0
  • Published —
In this study, researchers evaluated the outcomes of using lumateperone to treat the symptoms of schizophrenia.
  • Condition: Chorea
  • Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
  • Treatment Used: Various
  • Number of Patients: 0
  • Published —
The study researched the outcomes of treating chorea in patients with infectious, pharmacologic, metabolic, autoimmune disorders, or paraneoplastic syndromes.
  • Condition: Tardive Dyskinesia (TD)
  • Journal: NULL
  • Treatment Used: Deutetrabenazine
  • Number of Patients: 343
  • Published —
This study evaluated the long-term effectiveness and safety of deutetrabenazine in patients with tardive dyskinesia (disorder that results in involuntary, repetitive body movements; TD).
  • Condition: Tardive Dyskinesia (TD)
  • Journal: NULL
  • Treatment Used: Valbenazine
  • Number of Patients: 1573
  • Published —
This study tested the safety and efficacy of using valbenazine to treat patients with TD.
  • Condition: Tardive Dyskinesia (TD)
  • Journal: NULL
  • Treatment Used: Deutetrabenazine
  • Number of Patients: 343
  • Published —
This study tested the safety and efficacy of using deutetrabenazine to treat patients with TD.
  • Condition: Simultaneous Bilateral Ulnar Neuropathy Caused by Neuroleptic Treatment-Induced Tardive Dyskinesia
  • Journal: Medicine
  • Treatment Used: Adjusting Antipsychotic Drug and Anterior Transposition of Ulnar Nerve
  • Number of Patients: 1
  • Published —
This case report describes a 54-year-old Asian male with paranoid schizophrenia who developed simultaneous bilateral ulnar neuropathy caused by neuroleptic treatment-induced tardive dyskinesia (involuntary movements) treated with antipsychotic drug adjustment and anterior transposition of ulnar nerve.
  • Condition: Tardive Dyskinesia
  • Journal: Journal of clinical psychopharmacology
  • Treatment Used: Valbenazine
  • Number of Patients: 152
  • Published —
The purpose of the study was to assess the long-term effects of once-daily valbenazine in patients with tardive dyskinesia.
  • Condition: Tardive Movement Syndrome
  • Journal: Journal of clinical psychopharmacology
  • Treatment Used: Clozapine
  • Number of Patients: 35
  • Published —
This study tested the safety and efficacy of using clozapine to treat patients with Tardive movement syndrome.
  • Condition: Tardive Dyskinesia (TD) in Older and Younger Patients
  • Journal: International journal of geriatric psychiatry
  • Treatment Used: Valbenazine
  • Number of Patients: 0
  • Published —
This study evaluated the effects of once-daily valbenazine in older and younger adults with tardive dyskinesia (repetitive, involuntary movements; TD).
  • Condition: Huntington's Disease-Associated Tardive Dyskinesia and Chorea
  • Journal: Expert opinion on pharmacotherapy
  • Treatment Used: Deutetrabenazine
  • Number of Patients: 0
  • Published —
This study evaluated the use of deutetrabenazine in patients with Huntington's disease-associated tardive dyskinesia and chorea.
  • Condition: Tardive Dyskinesia (TD)
  • Journal: Current neurology and neuroscience reports
  • Treatment Used: VMAT2 inhibitors, Deutetrabenazine and Valbenazine
  • Number of Patients: 0
  • Published —
This review of the literature provided an update on the latest treatments for tardive dyskinesia (repetitive, uncontrolled movements;TD).
Showing 1-12 of 19